---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-22-000030"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2022-06-22T23:59:59+00:00"
generated_at: "2026-06-24T23:59:50.916637+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical amends loan agreement to set German subsidiary asset and income limits

## Summary
- German subsidiary GMBH exempted from subsidiary joinder requirements in loan agreement.
- GMBH cannot hold IP; cash limited to $7M and annual net income over €2M must be transferred to parent.
- Permitted foreign bank account aggregate limit raised to $10M from prior $10M (no change?) – actually increased from previous unspecified lower limit.
- Quarterly investment cap of $5M in GMBH added as Permitted Investment.

## SEC filing metadata
- accession: 0001609550-22-000030
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2022-06-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955022000030/0001609550-22-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955022000030/insp-20220615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-22-000030
- JSON: https://secwatch.observer/filing/0001609550-22-000030.json
- Plain text: https://secwatch.observer/filing/0001609550-22-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.